Cite

1. Brown JC, Gerhardt TE, Kwon E. Risk factors for coronary artery disease. Treasure Island (FL): StatPearls Publishing; 2022. Search in Google Scholar

2. Gupta RM, Hadaya J, Trehan A, Zekavat SM, Roselli C, Klarin D, et al. A genetic variant associated with five vascular diseases is a distal regulator of endothelin-1 gene expression. Cell 2017;170(3):522-33.e15.10.1016/j.cell.2017.06.049578570728753427 Search in Google Scholar

3. Adlam D, Olson TM, Combaret N, Kovacic JC, Iismaa SE, Al-Hussaini A, et al. Association of the PHACTR1/EDN1 genetic locus with spontaneous coronary artery dissection. J Am Coll Cardiol 2019;73(1):58-66.10.1016/j.jacc.2018.09.08530621952 Search in Google Scholar

4. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332(6163):411-5.10.1038/332411a02451132 Search in Google Scholar

5. Vane JR, Anggård EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990;323(1):27-36.10.1056/NEJM1990070532301062113184 Search in Google Scholar

6. Kelly JJ, Whitworth JA. Endothelin-1 as a mediator of cardiovascular disease. Clin Exp Pharmacol Physiol 1999;26(2):158-61.10.1046/j.1440-1681.1999.03011.x10065339 Search in Google Scholar

7. Nishiyama SK, Zhao J, Wray DW, Richardson RS. Vascular function and endothelin-1: tipping the balance between vasodilation and vasoconstriction. J Appl Physiol 2017;122(2):354-60.10.1152/japplphysiol.00772.2016533860227909229 Search in Google Scholar

8. Trindade M, Oigman W, Fritsch Neves M. Potential role of endothelin in early vascular aging. Curr Hypertens Rev 2017;13(1):33-40.10.2174/157340211366617041416573528413991 Search in Google Scholar

9. Kostov K. The causal relationship between endothelin-1 and hypertension: focusing on endothelial dysfunction, arterial stiffness, vascular remodeling, and blood pressure regulation. Life (Basel) 2021;11(9):986.10.3390/life11090986847203434575135 Search in Google Scholar

10. Barden AE, Herbison CE, Beilin LJ, Michael CA, Walters BN, Van Bockxmeer FM. Association between the endothelin-1 gene Lys198Asn polymorphism blood pressure and plasma endothelin-1 levels in normal and pre-eclamptic pregnancy. J Hypertens 2001;19(10):1775-82.10.1097/00004872-200110000-0001111593097 Search in Google Scholar

11. Asai T, Ohkubo T, Katsuya T, Higaki J, Fu Y, Fukuda M, et al. Endothelin-1 gene variant associates with blood pressure in obese Japanese subjects: the Ohasama Study. Hypertension 2001;38(6):1321-4.10.1161/hy1101.09533311751711 Search in Google Scholar

12. Treiber FA, Barbeau P, Harshfield G, Kang HS, Pollock DM, Pollock JS, et al. Endothelin-1 gene Lys198Asn polymorphism and blood pressure reactivity. Hypertension 2003;42(4):494-9.10.1161/01.HYP.0000091266.41333.1512963677 Search in Google Scholar

13. Tanaka C, Kamide K, Takiuchi S, Kawano Y, Miyata T. Evaluation of the Lys198Asn and –134delA genetic polymorphisms of the endothelin-1 gene. Hypertens Res 2004;27(5):367-71.10.1291/hypres.27.36715198485 Search in Google Scholar

14. Wiltshire S, Powell BL, Jennens M, McCaskie PA, Carter KW, Palmer LJ, et al. Investigating the association between K198N coding polymorphism in EDN1 and hypertension, lipoprotein levels, the metabolic syndrome and cardiovascular disease. Hum Genet 2008;123(3):307-13.10.1007/s00439-008-0481-018288492 Search in Google Scholar

15. Paré G, Serre D, Brisson D, Anand SS, Montpetit A, Tremblay G, et al. Genetic analysis of 103 candidate genes for coronary artery disease and associated phenotypes in a founder population reveals a new association between endothelin-1 and high-density lipoprotein cholesterol. Am J Hum Genet 2007;80(4):673-82.10.1086/513286185270417357073 Search in Google Scholar

16. Uchida Y, Sugiura S, Nakashima T, Ando F, Shimokata H. Endothelin-1 gene polymorphism and hearing impairment in elderly Japanese. Laryngoscope 2009;119(5):938-43.10.1002/lary.2018119358249 Search in Google Scholar

17. Zhu G, Carlsen K, Carlsen KH, Lenney W, Silverman M, Whyte MK, et al. Polymorphisms in the endothelin-1 (EDN1) are associated with asthma in two populations. Genes Immun 2008;9(1):23-9.10.1038/sj.gene.636444117960156 Search in Google Scholar

18. Li J, Yin W, Liu MS, Mao LJ, Wang XH. Potential correlation between EDN1 gene polymorphisms with preeclampsia. Eur Rev Med Pharmacol Sci 2020;24(4):1602-8. Search in Google Scholar

19. Rizk H, Hammad A, El-Said A, Wahba Y. Endothelin-1 RS5370 gene polymorphism in primary nephrotic syndrome: a case-control study. An Pediatr (Engl Ed) 2021;95(6):406-12.10.1016/j.anpedi.2020.04.03633317978 Search in Google Scholar

20. Lazurova Z, Habalova V, Mitro P. Association of polymorphisms in endothelin-1 and endothelin receptor a genes with vasovagal syncope. Physiol Res 2022;71(1):93-101.10.33549/physiolres.934689899767635043642 Search in Google Scholar

21. Jarray R, Allain B, Borriello L, Biard D, Loukaci A, Larghero J, et al. Depletion of the novel protein PHACTR-1 from human endothelial cells abolishes tube formation and induces cell death receptor apoptosis. Biochimie 2011;93(10):1668-75.10.1016/j.biochi.2011.07.01021798305 Search in Google Scholar

22. Jarray R, Pavoni S, Borriello L, Allain B, Lopez N, Bianco S, et al. Disruption of phactr-1 pathway triggers pro-inflammatory and pro-atherogenic factors: new insights in atherosclerosis development. Biochimie 2015;118:151-61.10.1016/j.biochi.2015.09.00826362351 Search in Google Scholar

23. Reschen ME, Lin D, Chalisey A, Soilleux EJ, O’Callaghan CA. Genetic and environmental risk factors for atherosclerosis regulate transcription of phosphatase and actin regulating gene PHACTR1. Atherosclerosis 2016;250:95-105.10.1016/j.atherosclerosis.2016.04.025491789727187934 Search in Google Scholar

24. Anttila V, Winsvold BS, Gormley P, Kurth T, Bettella F, McMahon G, et al. Genome-wide meta-analysis identifies new susceptibility loci for migraine. Nat Genet 2013;45(8):912-7.10.1038/ng.2676404112323793025 Search in Google Scholar

25. Pérez-Hernández N, Vargas-Alarcón G, Posadas-Sánchez R, Martínez--Rodríguez N, Tovilla-Zárate CA, Rodríguez-Cortés AA, et al. PHACTR1 gene polymorphism is associated with increased risk of developing premature coronary artery disease in Mexican population. Int J Environ Res Public Health 2016;13(8):803.10.3390/ijerph13080803499748927517945 Search in Google Scholar

26. O’Donnell CJ, Kavousi M, Smith AV, Kardia SL, Feitosa MF, Hwang SJ, et al. Genome-wide association study for coronary artery calcification with follow-up in myocardial infarction. Circulation 2011;124(25):2855-64.10.1161/CIRCULATIONAHA.110.974899339717322144573 Search in Google Scholar

27. Niemiec P, Zak I, Wita K. The 242T variant of the CYBA gene polymorphism increases the risk of coronary artery disease associated with cigarette smoking and hypercholesterolemia. Coron Artery Dis 2007;18(5):339-46.10.1097/MCA.0b013e328241d97a17627182 Search in Google Scholar

28. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18(6):499-502.10.1093/clinchem/18.6.499 Search in Google Scholar

29. Knol MJ, VanderWeele TJ, Groenwold RH, Klungel OH, Rovers MM, Grobbee DE. Estimating measures of interaction on an additive scale for preventive exposures. Eur J Epidemiol 2011;26(6):433-8.10.1007/s10654-011-9554-9311506721344323 Search in Google Scholar

30. Knol MJ, VanderWeele TJ. Recommendations for presenting analyses of effect modification and interaction. Int J Epidemiol 2012;41(2):514-20.10.1093/ije/dyr218332445722253321 Search in Google Scholar

31. Zou GY. On the estimation of additive interaction by use of the four-by- -two table and beyond. Am J Epidemiol 2008;168(2):212-24.10.1093/aje/kwn10418511428 Search in Google Scholar

32. Chen L, Qian H, Luo Z, Li D, Xu H, Chen J, et al. PHACTR1 gene polymorphism with the risk of coronary artery disease in Chinese Han population. Postgrad Med J 2019;95(1120):67-71.10.1136/postgradmedj-2018-13629830777881 Search in Google Scholar

33. Ford TJ, Corcoran D, Padmanabhan S, Aman A, Rocchiccioli P, Good R, et al. Genetic dysregulation of endothelin-1 is implicated in coronary micro-vascular dysfunction. Eur Heart J 2020;41(34):3239-52.10.1093/eurheartj/ehz915755747531972008 Search in Google Scholar

34. Hartopo AB, Sukmasari I, Puspitawati I, Setianto BY. Serum endothelin-1 correlates with myocardial injury and independently predicts adverse cardiac events in non-ST-elevation acute myocardial infarction. Int J Vasc Med 2020;2020:9260812.10.1155/2020/9260812742439832832158 Search in Google Scholar

35. Aggarwal PK, Jain V, Srinivasan R, Jha V. Maternal EDN1 G5665T polymorphism influences circulating endothelin-1 levels and plays a role in determination of preeclampsia phenotype. J Hypertens 2009;27(10):2044-50.10.1097/HJH.0b013e32832f7f3f19730395 Search in Google Scholar

36. Iwanicka J, Iwanicki T, Niemiec P, Nowak T, Krauze J, Grzeszczak W, et al. Relationship between rs854560 PON1 gene polymorphism and tobacco smoking with coronary artery disease. Dis Markers 2017;2017:1540949.10.1155/2017/1540949565113729118461 Search in Google Scholar

37. Salonen JT, Malin R, Tuomainen TP, Nyyssönen K, Lakka TA, Lehtimäki T. Polymorphism in high density lipoprotein paraoxonase gene and risk of acute myocardial infarction in men: prospective nested case-control study. BMJ 1999;319(7208):487-9.10.1136/bmj.319.7208.4872820110454401 Search in Google Scholar

eISSN:
2719-6313
Idioma:
Inglés
Calendario de la edición:
4 veces al año
Temas de la revista:
Medicine, Basic Medical Science, other, Clinical Medicine, Surgery, Public Health